TP53 and neoplasm: Although mutations in MEN1, DAXX (death domain associated protein), ATRX (alpha‐thalassemia‐X‐linked intellectual disability syndrome), and Tumor Protein 53 (TP53) are more likely to be responsible for promoting PanNET evolution and advancement,[3] the heterogeneity and mechanism underlying tumor malignancy are still unclear.